Wedge Capital Management Trims Johnson & Johnson Stake

Institutional investor reduces position in pharmaceutical giant by 7% in Q4

Mar. 31, 2026 at 11:18am

Got story updates? Submit your updates here. ›

Wedge Capital Management L L P NC, an institutional investor, decreased its position in Johnson & Johnson (NYSE:JNJ) by 7.0% during the fourth quarter, according to a recent SEC filing. The firm now owns 139,905 shares of the company's stock, valued at $28,953,000.

Why it matters

Johnson & Johnson is a bellwether stock in the healthcare sector, and changes in institutional ownership can signal broader market trends or investor sentiment around the company's performance and outlook.

The details

According to the filing, Wedge Capital Management sold 10,586 shares of Johnson & Johnson stock during the fourth quarter. The firm now holds a total of 139,905 shares, down from 150,491 shares at the end of the prior quarter.

  • Wedge Capital Management filed the 13F report for the fourth quarter of 2025 on March 31, 2026.

The players

Wedge Capital Management L L P NC

An institutional investment firm that manages a portfolio of stocks, bonds, and other assets on behalf of clients.

Johnson & Johnson

A multinational pharmaceutical and consumer goods company headquartered in New Brunswick, New Jersey.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

The takeaway

This filing highlights the shifting investment landscape, as institutional investors reevaluate their positions in major healthcare companies like Johnson & Johnson. The reduced stake could signal broader concerns about the company's growth prospects or the overall direction of the sector.